Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
In conclusion, our findings indicate that serum Ang2 is a potential novel biomarker for both diagnosis and prognosis in HCC.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Junjie Ao, Tetsuhiro Chiba, Hiroaki Kanzaki, Kengo Kanayama, Shuhei Shibata, Akane Kurosugi, Terunao Iwanaga, Motoyasu Kan, Takafumi Sakuma, Na Qiang, Yaojia Ma, Ryuta Kojima, Yuko Kusakabe, Masato Nakamura, Kazufumi Kobayashi, Soichiro Kiyono, Naoya Kano Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Study | Urology & Nephrology